Arterial Cannula Market Size & Forecast Report - 2026 to 2030

The global arterial cannula market size was valued at around USD 19 billion in 2021 and anticipated to grow at a significant CAGR of over 7% during the forecast period from 2022 to 2028. The rising prevalence of cardiovascular diseases around the world is a primary factor driving the market growth. According to the CDC (Centers for Disease Control and Prevention), coronary heart disease is one of the most common types of heart disease in the United States and is estimated to cause 382,820 deaths in 2020. It is further estimated that about 20.1 million adults with age 20 years and older have CAD.

The increasing use of arterial cannula in various procedures such as cardiopulmonary pass surgery, extracorporeal membrane oxygenation, and dialysis is further anticipated to fuel the market over the forecast period. Furthermore, the increasing adoption of minimally invasive procedures due to their various advantages such as lower pain and less recovery time is further estimated to uplift the market growth. Moreover, the technological advancement in healthcare, growing expenditure, and changing lifestyles are further anticipated to propel the market growth.

Market Drivers:

Increasing Cardiovascular Diseases: The prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and cardiac arrest, is increasing globally. Arterial cannulas play a crucial role in these conditions by providing access to the arterial system for various diagnostic and therapeutic procedures, including blood sampling, monitoring, and extracorporeal circulation during cardiac surgeries.

Growing Geriatric Population: The aging population is prone to cardiovascular diseases and often requires surgical interventions or critical care management. As the elderly population grows, the demand for arterial cannulas is expected to rise. Geriatric patients undergoing cardiac procedures or requiring hemodynamic monitoring often require arterial access for accurate diagnosis and treatment.

Technological Advancements: Technological advancements in arterial cannula design and materials have improved their safety, efficacy, and ease of use. Innovations such as soft-tipped cannulas, biocompatible materials, and integrated monitoring features enhance patient comfort, reduce complications, and facilitate accurate arterial pressure measurements.

Increasing Cardiac Surgeries: The growing number of cardiac surgeries, including coronary artery bypass grafting (CABG), valve replacement, and aortic surgeries, drives the demand for arterial cannulas. These cannulas are essential for establishing extracorporeal circulation during cardiopulmonary bypass, providing oxygenated blood to the body, and monitoring arterial pressures during the procedure.

Rising Demand for Minimally Invasive Procedures: Minimally invasive cardiac procedures, such as percutaneous coronary interventions (PCI) and transcatheter aortic valve replacement (TAVR), are becoming increasingly popular due to their reduced invasiveness, shorter recovery times, and lower complication rates. Arterial cannulas are utilized in these procedures to gain arterial access for catheter insertion and to monitor hemodynamic parameters.

Increasing Focus on Patient Safety: Patient safety is a significant concern in healthcare, and arterial cannulas play a vital role in ensuring safe and accurate monitoring and intervention. The use of arterial cannulas allows continuous monitoring of arterial blood pressure and facilitates timely intervention in case of hemodynamic instability, helping to improve patient outcomes.

Growing Healthcare Expenditure: Increasing healthcare expenditure and investments in healthcare infrastructure, particularly in developing regions, contribute to the growth of the arterial cannula market. The availability of advanced medical facilities and the rising demand for cardiovascular procedures drive the adoption of arterial cannulas in these regions.

Technological Integration and Connectivity: Arterial cannulas are increasingly being integrated with monitoring systems and connected to electronic medical records, allowing real-time monitoring and seamless data integration. This integration enhances patient care, facilitates data analysis, and supports clinical decision-making.

Market Snapshot:

Market Insights:

By size, the 20-22 Fr segment is accounted to hold the largest market share in 2021

The global arterial cannula market is bifurcated into size, application, end-user, and geography. On the basis of size, the market is further segmented into 14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, and others. The 20-22 Fr size cannula segment dominated the global market in 2021 and estimated to hold the largest revenue share of around 1/4 market share by the end of the analysis period. The increasing use of the product in ECMO procedures is one of the key factor to drive the segment growth. On the flip side, the 35-36 Fr segment is anticipated to register the fastest growth rate over the forecast period.

By application, the ECMO segment is anticipated to dominate the global market by 2028

On the basis of application, the market is segmented into cardiopulmonary bypass surgery, extracorporeal membrane oxygenation (ECMO), and others. The ECMO application segment dominated the global arterial cannula market in 2021 and expected to maintain its dominance over the forecast period. The high prevalence rate of cardiovascular disorders and the increasing incidence of lung failure are some major factors driving the segment growth. As per the latest information shared by the American Lung Association in 2022, about 37 million Americans live with chronic lung diseases such as asthma and COPD, which includes emphysema and chronic bronchitis. According to the WHO (World Health Organization), COPD is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.

To know more about the study, request sample papers

The arterial cannula comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2022 to 2028. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The arterial cannula market research report presents the analysis of each segment from 2019 to 2028 considering 2021 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2022 to 2028.

Historical & Forecast Period

• 2019-20 – Historical Year
• 2021 – Base Year
• 2022-2028 – Forecast Period

Market Segmentation:

By Size:

• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29- 31 Fr
• 32-34 Fr
• 35-36 Fr

By Application:

• Cardiopulmonary Bypass Surgery
• Extracorporeal Membrane Oxygenation (ECMO)
• Others

By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

By region, North America dominated the global market in 2021 owing to the increasing prevalence of chronic kidney diseases

On the basis of region, North America dominated the global arterial cannula market in 2021 and expected to grow at the same trend over the forecast period. The rising prevalence of chronic lung disease and the growing number of cardiac surgeries are some major factors driving the market growth in the region. Furthermore, the increasing prevalence rate of chronic kidney diseases is further expected to fuel the market growth in North America. According to the CDC (Centers for Disease Control and Prevention), in 2021, it is estimated that more than 37 million adults have chronic kidney disease in the United States.

Geographically, the arterial cannula market report comprises dedicated sections centering on the regional market revenue and trends. The arterial cannula market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The arterial cannula market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Arterial cannula market estimates have also been provided for the historical years 2019 & 2020 along with forecasts for the period from 2022 – 2028.

Competitive Assessment:

Some of the major market players operating in the global arterial cannula market are Medtronic, plc., LivaNova plc, Edward Lifesciences, Getinge AB, and Fresenius Medical Care. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Medtronic, plc.
• LivaNova plc
• Edward Lifesciences
• Getinge AB
• Fresenius Medical Care
• BD
• Nipro Corp.
• Andocor
• Freelife Medical GmbH
• Surgical Holdings
• Kangxin Medical

Key Questions Answered by Arterial Cannula Market Report

• Global arterial cannula market forecasts from 2022-2028
• Regional market forecasts from 2022-2028 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2022-2028 covering 15 major countries from the regions as mentioned above
• Arterial cannula submarket forecasts from 2022-2028 covering the market by size, application, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level arterial cannula markets from 2022-2028
• Competitive Landscape and market positioning of top 10 players operating in the market